These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11878334)

  • 1. Difficulties in negotiating research access.
    Ames JC; Thompson S; Thurston MN
    Bull Med Ethics; 2001 Mar; (166):15-7. PubMed ID: 11878334
    [No Abstract]   [Full Text] [Related]  

  • 2. A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs.
    Rogers AS; Schwartz DF; Weissman G; English A;
    IRB; 1999; 21(1):6-10. PubMed ID: 11657967
    [No Abstract]   [Full Text] [Related]  

  • 3. Caregivers as subjects of clinical drug trials: a review of human subjects protection practices in published studies of Alzheimer's disease pharmacotherapies.
    Lingler JH; Parker LS; DeKosky ST; Schulz R
    IRB; 2006; 28(3):11-8. PubMed ID: 17036439
    [No Abstract]   [Full Text] [Related]  

  • 4. Expanding disclosure of conflicts of interest: the views of stakeholders.
    Brody BA; Anderson C; McCrary SV; McCullough L; Morgan R; Wray N
    IRB; 2003; 25(1):1-8. PubMed ID: 12833897
    [No Abstract]   [Full Text] [Related]  

  • 5. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
    Caulfield T
    Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychology faculty satisfaction and compliance with IRB procedures.
    Liddle BJ; Brazelton EW
    IRB; 1996; 18(6):4-6. PubMed ID: 11654744
    [No Abstract]   [Full Text] [Related]  

  • 8. Ten questions institutional review boards should ask when reviewing international clinical research protocols.
    Fitzgerald DW; Wasunna A; Pape JW
    IRB; 2003; 25(2):14-8. PubMed ID: 12833903
    [No Abstract]   [Full Text] [Related]  

  • 9. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
    Puttagunta PS; Caulfield TA; Griener G
    Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coercion in the recruitment and retention of human research subjects, pharmaceutical industry payments to physician-investigators, and the moral courage of the IRB.
    DeRenzo EG
    IRB; 2000; 22(2):1-5. PubMed ID: 11883465
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethics committees in Asia.
    de Castro LD
    Not Polit; 2002; 18(67):120-2. PubMed ID: 15282929
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical trial in a developing country: many questions, few answers.
    Kietinun S; Gupte MD; Sengupta A
    Issues Med Ethics; 2003; 11(3):89-90. PubMed ID: 16335511
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving protection for research subjects in France: analysis of regional ethics committees.
    Fauriel I; Moutel G; Duchange N; Callies I; François I; Huriet C; Hervé C
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):312-8. PubMed ID: 15546685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Module five: implementation of ethics review.
    Dhai A
    Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confidentiality: more than a linkage file and a locked drawer.
    Easter MM; Davis AM; Henderson GE
    IRB; 2004; 26(2):13-7. PubMed ID: 15069972
    [No Abstract]   [Full Text] [Related]  

  • 16. [Integration of clinical trial agreement process in Ethics Committee evaluation timelines. Pilot study MINT&R(®)-cec].
    Briones Carrillo L; Pérez Gladiador I; Villavicencio Miguel L; Portolés Pérez A
    Med Clin (Barc); 2013 May; 140(10):466-72. PubMed ID: 23453844
    [No Abstract]   [Full Text] [Related]  

  • 17. Financial conflicts of interest and protection of human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of human subjects protection at CDC/ATSDR.
    Santelli J; Ginn E; Speers MA
    IRB; 2000; 22(4):1-7. PubMed ID: 11883474
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers facing increasing costs for clinical research, with few solutions.
    Erdmann J
    J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
    [No Abstract]   [Full Text] [Related]  

  • 20. A central institutional review board for multi-institutional trials.
    Christian MC; Goldberg JL; Killen J; Abrams JS; McCabe MS; Mauer JK; Wittes RE
    N Engl J Med; 2002 May; 346(18):1405-8. PubMed ID: 11986418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.